11 subscribers
使用Player FM应用程序离线!
值得一听的播客
赞助


Market Access for Groundbreaking Treatments – A Case Study of Pulsed Field Ablation (PFA) with Clarivate
Manage episode 444403535 series 2892873
Navigating the complexities of groundbreaking treatments can create headwinds. With innovations like Pulsed Field Ablation (PFA) at the forefront, challenges such as financial uncertainties, regulatory shifts, and global adoption become paramount. Join us for an insightful discussion on how global partners address these challenges, focusing on safety & efficacy, financial impacts, and clinical differentiation in areas where baseline data is scarce.
Background on PFA: Pulsed Field Ablation (PFA) is a groundbreaking nonthermal energy source that is rapidly transforming atrial fibrillation (AF) treatment, affecting up to 38 million people worldwide. Unlike traditional heat or cold methods, PFA uses high-voltage electrical fields in microseconds for precise cell necrosis, marking a significant advancement in cardiology.
Guests:
- Juliane Ray, Global Head of Medtech Strategy, Clarivate (Moderator)
- Annette Boyle, Editor, BioWorld MedTech
- Dee Chaudhary, Principal Commercial Strategy Consulting, Clarivate
- Pankhil Ghandhi, Senior Team Lead, Medtech Insights, Clarivate
- David Begley, MD, Clinical Director in Cardiology, Royal Papworth Hospital
Follow Medical Alley on social media on LinkedIn, Facebook, X and Instagram.
256集单集
Manage episode 444403535 series 2892873
Navigating the complexities of groundbreaking treatments can create headwinds. With innovations like Pulsed Field Ablation (PFA) at the forefront, challenges such as financial uncertainties, regulatory shifts, and global adoption become paramount. Join us for an insightful discussion on how global partners address these challenges, focusing on safety & efficacy, financial impacts, and clinical differentiation in areas where baseline data is scarce.
Background on PFA: Pulsed Field Ablation (PFA) is a groundbreaking nonthermal energy source that is rapidly transforming atrial fibrillation (AF) treatment, affecting up to 38 million people worldwide. Unlike traditional heat or cold methods, PFA uses high-voltage electrical fields in microseconds for precise cell necrosis, marking a significant advancement in cardiology.
Guests:
- Juliane Ray, Global Head of Medtech Strategy, Clarivate (Moderator)
- Annette Boyle, Editor, BioWorld MedTech
- Dee Chaudhary, Principal Commercial Strategy Consulting, Clarivate
- Pankhil Ghandhi, Senior Team Lead, Medtech Insights, Clarivate
- David Begley, MD, Clinical Director in Cardiology, Royal Papworth Hospital
Follow Medical Alley on social media on LinkedIn, Facebook, X and Instagram.
256集单集
所有剧集
×
1 Finding Solutions Through Innovation and Collaboration with Jon Solberg of Pepin Manufacturing 17:36
欢迎使用Player FM
Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。